Clinical Trial Update: Comparison of Thrombgolytic and Anticoagulation Therapy in Submassive Pulmonary Embolism [Phase 4]

View source ↗

Summary

Phase 4 trial comparing thrombolytic therapy with anticoagulation in submassive pulmonary embolism has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Embolism

Drugs mentioned

• Anticoagulation therapy (general)
• Thrombolytic therapy (general)

Snippet

Sponsor: University Hospital Ostrava | Conditions: Pulmonary Embolism | Phase 4 | Status: COMPLETED